PPIs do not interfere with anti-platelet drugs, study concludes
BOSTON Drugs commonly used to treat heartburn and acid-reflux disease don’t interfere with drugs used to prevent clotting in patients with heart disease, according to a new study.
The 13,608-patient study, led by Michelle O’Donoghue and colleagues at Brigham and Women’s Hospital in Boston. and published online and in the upcoming edition of medical journal The Lancet, found that such proton-pump inhibitors as AstraZeneca’s Prilosec (omeprazole) and Nexium (esomeprazole) did not endanger patients when combined with such anti-platelet drugs as Bristol-Myers Squibb’s and Sanofi-Aventis’ Plavix (clopidogrel) and Eli Lilly & Co.’s Effient (prasugrel).
Patients given anti-platelet drugs following heart attack or unstable angina are often given proton pump inhibitors to reduce the risk of gastrointestinal bleeding, but recent studies have suggested that proton-pump inhibitors could reduce the effectiveness of the anti-platelet drugs, increasing the risk of heart attack and stroke. The new study could relieve fears among patients, healthcare providers and the drugs’ manufacturers.
“The current findings do not support the need to avoid concomitant use of proton pump inhibitors, when clinically indicated, in patients receiving clopidogrel or prasugrel,” the authors wrote in their conclusion.
Walgreens announces Pharmacy Management Excellence program with Caterpillar
The news that Walgreens has reached an agreement with Caterpillar to help the company curb healthcare costs for its 70,000 employees, retirees and eligible dependents is one more indicator that the private sector cannot wait for healthcare reform and that pharmacy retailers are taking a greater role on the front lines of health care.
As explained in the article, Walgreens, through its Pharmacy Management Excellence program, will make transparent the prescription drug-pricing model, in turn, eliminating unnecessary and hidden costs for Caterpillar.
Walgreens and Caterpillar are also exploring, through Walgreens Complete Care and Well-Being program, other ways to develop an integrated health care and pharmacy program. The Complete Care and Well-Being program combines worksite health centers, in-store clinics and pharmacies with the discount drug offering
By leveraging its resources, Walgreens is positioning itself along the frontlines of the healthcare and sending the message that retail pharmacy is helping to drive healthcare reform and is a critical player in improving employees’ health and well-being.
As previously mentioned by Drug Store News, the more the private sector leads the way on this, the more likely that reform will work for them, as well as the rest of America.
Neosporin expands with lip care line
NEW YORK Neosporin, a Johnson & Johnson Consumer Cos. brand, is diving into the dry lip segment with the launch of its new Neosporin Lip Health daily hydration therapy and Neosporin Lip Health overnight renewal therapy.
The new products, which are shipping now, will join a portfolio of existing Neosporin products, including Neosporin LT Lip Treatment for the treatment of cold sores and severely dry chapped lips.
The new lip products are clinically shown to restore visibly healthier lips in three days, according to the company.
Neosporin Lip Health daily hydration therapy contains SPF 20 to protect lips from sunburn and both formulas feature a patented combination of lipids and antioxidants to soften and smooth lips. Peptides, vitamins and emollients also help to nourish and strengthen lips over time.
Both products have a suggested retail price of $4.99.